Metastatic ovarian cancer
Kiriushchenkov, A.P.
Fel'dsher i Akusherka 52(10): 58-61
1987
ISSN/ISBN: 0014-9772 PMID: 3436455 Document Number: 300780
Document emailed within 1 workday
Related Documents
Speiser, P.; Wanner, C.; Breitenecker, G.; Kohlberger, P.; Kainz, C. 1995: CD-44 is not involved in the metastatic spread of ovarian cancer in vivo Anticancer Research 15(6b): 2767-2769Cortés, J.; Uriz, A.; Terrasa, J.; Rifá, J.; Rosselló, J.J.; Llompart, M. 1986: Ovarian cancer metastatic to the kidney: case report European Journal of Gynaecological Oncology 7(3): 206-209
Iyibozkurt, A.C.; Akhan, S.E.; Topuz, S.; Citil, I.; Berkman, S. 2005: Laparoscopic evaluation of metastatic ovarian cancer: a case report European Journal of Gynaecological Oncology 26(1): 123-124
Van Nagell, J.R.; Kim, E.; Casper, S.; Primus, F.J.; Bennett, S.; DeLand, F.H.; Goldenberg, D.M. 1980: Radioimmunodetection of primary and metastatic ovarian cancer using radiolabeled antibodies to carcinoembryonic antigen Cancer Research 40(3): 502-506
Fukuyama, A.; Yokoyama, Y.; Wada, J.; Hashimoto, T.; Oda, T.; Sato, S.; Mizunuma, H. 2009: Two cases of ovarian cancer at an early stage incidentally detected using transvaginal ultrasonography in screening: importance of interval for ovarian cancer screening and selection of population with a high risk of ovarian cancer European Journal of Gynaecological Oncology 30(2): 208-210
Amrein, P.C.; Coleman, M.; Richards, F.; Bhardwaj, S.; Kennedy, B.J.; Haurani, F.I.; Frelick, R.W.; Pastmantier, M.W.; Herschkopf, R. 1984: Treatment of metastatic ovarian carcinoma with amsacrine: a cancer and leukemia group B phase Ii study Cancer Treatment Reports 68(11): 1397-1398
Hartge, P.; Hayes, R.; Reding, D.; Sherman, M.E.; Prorok, P.; Schiffman, M.; Buys, S. 2000: Complex ovarian cysts in postmenopausal women are not associated with ovarian cancer risk factors: preliminary data from the prostate, lung, colon, and ovarian cancer screening trial American Journal of Obstetrics and Gynecology 183(5): 1232-1237
Murgić, J.; Prpić, M.; Kirac, I.; Camino-Varela, A.-M.; Bolanca, A.; Kusić, Z. 2012: Dermatomyositis as paraneoplastic syndrome of peritoneal and ovarian relapse after long-term complete remission in patient with metastatic bilateral breast cancer Collegium Antropologicum 36(1): 325-329
Studzinski, Z.; Zajewski, W. 2002: Bilateral metastatic ovarian tumors (Krukenberg's tumors) in the course of stomach cancer Archives of Gynecology and Obstetrics 267(2): 95-97
Cerea, G.; Vaghi, M.; Ardizzoia, A.; Villa, S.; Bucovec, R.; Mengo, S.; Gardani, G.; Tancini, G.; Lissoni, P. 2003: Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinations Anticancer Research 23(2c): 1951-1954
Suzuki, M.; Sekiguchi, I.; Tamada, T.; Sakurabayashi, I.; Kawai, T. 1985: Clinical evaluation of a cancer antigen CA125 associated with ovarian cancer. (III) Serum CA125 levels in patients with ovarian cancer and other gynecological tumors Rinsho Byori. Japanese Journal of Clinical Pathology 33(2): 173-177
Rose, P.G.; Hunter, R.E. 1994: Advanced ovarian cancer in a woman with a family history of ovarian cancer, discovered at referral for prophylactic oophorectomy. A case report Journal of Reproductive Medicine 39(11): 908-910
Tanaka, K. 1989: Ovarian cancer--assessment of methods for cytogenetic analysis and chromosome aberrations found in ovarian cancer Rinsho Byori. Japanese Journal of Clinical Pathology Spec no 80: 268-280
Yang, J.-L.; Jackson, P.; Yu, Y.; Russell, P.J.; Markovic, B.; Crowe, P.J. 2002: Expression of the KAI1 metastasis suppressor gene in non-metastatic versus metastatic human colorectal cancer Anticancer Research 22(6a): 3337-3342
Du Bois, A.; Lück, H.J.; Meier, W.; Möbus, V.; Costa, S.; Richter, B.; Warm, M.; Bauknecht, T.; Schröder, W.; Olbricht, S.; Nitz, U.; Jackisch, C. 1997: Carboplatin/paclitaxel versus cisplatin/paclitaxel as first-line chemotherapy in advanced ovarian cancer: an interim analysis of a randomized phase IIi trial of the Arbeitsgemeinschaft Gynäkologische Onkologie Ovarian Cancer Study Group Seminars in Oncology 24(5 Suppl 15: S15
Chou, Y-Ching.; Chen, Y-Jen.; Lai, C-Ru.; Wang, P-Hui.; Hsin-Chan; Yuan, C-Chung. 2006: Cyclooxygenase-2 expression is higher in ovarian cancer tissue adjacent to endometriosis than in ovarian cancer without comorbid endometriosis European Journal of Obstetrics Gynecology and Reproductive Biology 124(1): 101-105
Ivanov, S.; Batashki, I. 2008: Five years survival in patients with endometrioid ovarian cancer versus patients with serous ovarian cancer Akusherstvo i Ginekologiia 47(5): 9-11
Datta, C.K.; Gasataya, J.D.; de la Pena, C.A.; Fischer, H. 1979: Metastatic ovarian carcinoids: a case report West Virginia Medical Journal 75(11): 321-325
Murakami, F.; Kiyozuka, Y.; Nishimura, H.; Imamura, K.; Yakushiji, M.; Noda, T.; Adachi, S.; Ito, K.; Tamori, N.; Shintani, M. 1993: Etoposide/cis-platinum (CDDP) combined chemotherapy for ovarian cancer: evaluation of optimum schedule for CDDP administration in chronic continuous exposure of ovarian cancer cells to low-dose etoposide in vitro Nihon Sanka Fujinka Gakkai Zasshi 45(2): 125-132
Milsom, I.; Odlind, V. 2008: Oral contraceptives give long-lasting protection against ovarian cancer. use of oral contraceptives can explain reduced incidence of ovarian cancer in Sweden Lakartidningen 105(10): 715-716